Continuous Lactate Monitoring With Real-Time Alert Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current lactate monitoring methods are reactive and provide only single-point measurements, failing to capture transient fluctuations and predict patient outcomes, leading to delayed treatment and potential misdiagnosis.

Innovation Solution

A continuous lactate monitoring system with an implantable sensor that continuously records lactate levels, transmitting data to a computing device for analysis and generating real-time alerts and notifications based on predefined alarm conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If serial blood draws are used for lactate measurement, then device complexity is reduced, but measurement precision and reliability deteriorate due to single-point measurements missing transient fluctuations

Engineering Contradiction:
Improvemeasurement system complexityVSAvoidlactate level detection accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent implements continuous lactate monitoring through an implantable sensor that continuously measures lactate levels in the patient's interstitial fluid, replacing discrete serial blood draws with an ongoing measurement process that captures transient fluctuations and provides real-time data for early deterioration detection

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent replaces the mechanical blood draw process with an implantable electrochemical sensor that directly measures lactate in interstitial fluid, eliminating the need for repeated needle insertions and laboratory processing while providing continuous real-time measurements

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Loss of time

If periodic laboratory measurements are used, then loss of time for treatment response is reduced, but measurement precision deteriorates due to intervals between measurements missing rapid lactate changes

Engineering Contradiction:
Improvetime to detect lactate changesVSAvoidlactate level detection accuracy
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The continuous monitoring system maintains constant measurement of lactate levels, eliminating measurement intervals and ensuring that rapid lactate changes are captured immediately, enabling real-time detection of deterioration without the time loss associated with periodic sampling

Inventive Principle:
Principle #20Continuity of useful action

3Reliability

If continuous monitoring with implantable sensor is implemented, then measurement precision and reliability improve, but device complexity and ease of operation worsen due to implantation requirement

Engineering Contradiction:
Improvecontinuous monitoring reliabilityVSAvoidsystem deployment difficulty
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The implantable sensor is installed during an initial procedure and then operates continuously without requiring repeated patient interactions, making the initial implantation effort pay dividends through sustained reliable monitoring that eliminates the need for repeated blood draws and laboratory visits

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20250352061A1Methods and systems for continuous analyte monitoring
Publication Date: 2025.11.20 ABBOTT DIABETES CARE INC
  • US20250352061A1 patent drawing
  • US20250352061A1 patent drawing
  • US20250352061A1 patent drawing

AI summary

A continuous analyte monitoring system, includes a continuous analyte monitor, the continuous analyte monitor configured to generate analyte data based on the patient's measured analyte levels, the continuous analyte monitor having a transmitter configured to transmit the analyte data. In some embodiments, the continuous analyte monitoring system is a continuous lactate monitoring system. The system also includes an external transmitter that is configured to receive the lactate data from the transmitter and a computing device connected to the continuous analyte monitor through the external transmitter. The continuous analyte monitoring system is implemented within a distributed diagnostic system that generates customized visual elements for alerts and notifications that are communicated to multiple distributed downstream recipient devices.